Epstein Secrets

uthern Trust Co. - Fixed Income (Morgan Stanley) Charles Schwab 8.0% Preferred 525 par 7/27/15 40,000 1

000 275,655 124,785 -1.375.215 Avalanche Ellotedinoisgles now called Adverum Biotechnologles 4/20/15 10,000 298.806 28,500 25,500 -373,106 BASF ADR 4/13/15 5000 508,056 486,430 472,250 -35.806 Bank of New York Mellon 6/25/14 250,000 9.076,406 11,765,000 11,780.000 2,703.594 Biogen I

uthern Trust Co. - Fixed Income (Morgan Stanley) Charles Sthweb 6.0% Preferred 525par 7/27/15 40000 1,0

0,000 151,575 164,970 -1.335.030 Avalanche Blotechnologies now called Adverum Blotechnologles 4/20/15 10,000 398,606 25 030 25500 -373.106 BASF ADR 4/13/15 5,000 508,056 466,450 476.350 -31,708 Bank of New York Mellon 6/25/14 250,000 12,755,000 0 Biogen Idec Inc 2114/12 2,095 250,4

uthern Trust Co. - Fixed income (Morgan Stanley) Charles Schwab 8.0% Preferred $25 par 727/15 40,000 1,

500.000 151.575 164,970 -1.335.030 Avalanche Biotechnoiegles now called Adverum Beledinolcoes 4120115 10000 398,606 25,000 25500 -373,108. BASF ADR 4/13/15 ‘000 508,056 466,450 476,350 -31,706 Bank of New York Mellon 6/25/14 250,000 9,076 406 12,755,000 - -9,076 408 Biogen Idec Inc

uthern Trutt CO. - Fixed Income (Morgan Stanley) Charles Schwab 6.0% Preferred 525 pat 7/27/15 40,000 1

51.575 164,970 -1,335.030 1,50000 Avalanche Biotechnologies now called Advorum Btotochnolowes 4/20/16 10,000 398,606 25,000 25,500 373,106 BASF ADR 4/13/15 5,000 508.056 466,450 476,350 -31,706 Bank of New York Mellon 6/25/14 250.000 9.076.406 12,755,000 -9,076,406 356.236 Biogen Id

uthern Trust Co. - Fixed Income (Morgan Stanley) Charles Schwab 6.0% Preferred $25 per 7/27/15 40,000 1

,000 151,575 164,970 -1.335.030 Avalanche Biotechnologies now called Adverum Biotechnologies 4/20/15 10.000 398,608 25,000 25,500 -373,106 BASF ADR 4/13/15 5,000 508,056 466,450 478,350 -31,706 Bank of New York Mellon 6/25/14 2561,000 12,755,000 - 0 Blogen Ides Inc 2/14/12 2.095 2

uthern Trust Co. - Fixed Income (Morgan Stanley) Charles Schwab 6.0% Preferred $25 par 7/27/15 40.000 1

.500.000 124,785 151,575 Avalanche Biotechnologies now called Adverum Biotechnologies 4/20/15 10 000 398,606 25500 25,000 -373 606 -41,606 BASF ADR 4/13/15 5000 508,056 472,250 486,450 Bank of New York Mellon 6/25/14 2517,000 9,076,406 11,780,000 12,755,000 3,678594 318.044 Blogen I

n Trust Co. - Fixed Income (Interactive Brokers) Charles Schwab 6.0% Preferred $25 par 7/27/15 40,000 1

o Global Management 3/31/11 263,157 4,999,983 8,807,865 9,407,863 4,407,880 Broadcom Ltd 10/13/17 4,000 985,931 1,027,600 992,120 6,189 BASF ADR 4/13/15 5,000 508,056 549,400 586,000 77,944 Blogen Idec Inc 2/14/12 2,095 250.455 667,404 728.662 478,207 Centene Corp W8/14 15,550

00,000 3,009,819 3,105,000 3,142,500 132,682 Charles Schwab 6.0% Preferred 325 par 7/27/15 40,000 1

/17 314,000 53,321,627 52,682,920 51,891,640 -1,429.987 Apollo Global Management 3/31/11 263.157 4.999.983 7.794.710 7.589,448 2.589.465 BASF ADR 4/13/15 5,000 508,056 507,800 521,000 12,944 Berkshire Hathaway 2/5/18 6 1,852.362 1,794,600 1,743,900 -108,482 Berkshire Hathaway 312

uthern Trust Co. - Fixed Income (Morgan Stanley) Charles Schwab 6.0% Preferred $25 per 7/27/15 40,000 1

,000 151,575 164,970 -1.335.030 Avalanche Biotechnologies now called Adverum Biotechnologies 4/20/15 10.000 398,608 25,000 25,500 -373,106 BASF ADR 4/13/15 5,000 508,056 466,450 478,350 -31,706 Bank of New York Mellon 6/25/14 2561,000 12,755,000 - 0 Blogen Ides Inc 2/14/12 2.095 2

uthern Trutt CO. - Fixed Income (Morgan Stanley) Charles Schwab 6.0% Preferred 525 pat 7/27/15 40,000 1

51.575 164,970 -1,335.030 1,50000 Avalanche Biotechnologies now called Advorum Btotochnolowes 4/20/16 10,000 398,606 25,000 25,500 373,106 BASF ADR 4/13/15 5,000 508.056 466,450 476,350 -31,706 Bank of New York Mellon 6/25/14 250.000 9.076.406 12,755,000 -9,076,406 356.236 Biogen Id